RIVA-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetine
Brand(s)
Last updated
Summary
Product
RIVA-Fluoxetine 10 mg capsule
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|---|---|---|---|---|
| Laboratoire RIVA | RIVA-Fluoxetine 10 mg capsule | DIN 02305461 | Capsule | Fluoxetine hydrochloride 10 mg | D2271, D3262 |
Issue
Affected lots may exceed the interim acceptable intake limit for N-nitroso-fluoxetine.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Related recalls and alerts
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Laboratoire Riva Inc.
660 Boul. Industriel
Blainville Quebec J7C 3V4 Canada
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-77668
Get notified
Receive notifications for new and updated recalls and alerts by category.